Browse by Industry
Filter News
Found 40,570 articles
-
Lots of interesting biotech news from Asia, Europe and elsewhere was reported this week. From tapeworms to using a breathalyzer test in lung cancer diagnostics, the global biotech industry is exploding with ideas.
-
Since Amgen shut down its Bothell, Wash. site in 2014, life science employment growth has increased 13 percent across the state. According to The Seattle Times, companies across the region are in a scaling up process.
-
Dicerna Bolsters Leadership Team to Support Continued Growth
2/21/2019
Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the addition of three industry veterans to the Company’s management team
-
Teleflex Reports Fourth Quarter and Full Year 2018 Results; Provides 2019 Guidance
2/21/2019
Fourth Quarter 2018 Revenues of $641.6 million, up 7.8% Versus Prior Year Period; up 9.4% on a Constant Currency Basis
-
Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with Janssen
2/21/2019
Therapeutic potential of Morphic pipeline expanded by inclusion of both integrin inhibitor and activator research
-
Autolus Therapeutics to Announce Financial Results for the Transition Period from October 1, 2018 to December 31, 2018 and Host Conference Call on February 25, 2019
2/21/2019
Autolus Therapeutics plc announced that the company will release its operating and financial results for the transition period from October 1, 2018 to December 31, 2018 before the opening of U.S. markets on Monday, February 25, 2019.
-
Tooth Fairy payouts plunge for second consecutive year
2/21/2019
Delta Dental celebrates 20+ years of tracking the Tooth Fairy's U.S. annual giving
-
Innovus Pharma Announces Regulatory Filings by its International Distribution Partner, Lavasta Pharma, for ProstaGorx® in Certain Gulf Countries
2/21/2019
Innovus Pharmaceuticals, Inc. announced the submission of regulatory filings by its international distribution partner, Lavasta Pharma FZ-LLC, a company based in Dubai for the commercialization of ProstaGorx® in the United Arab Emirates and Kuwait.
-
Gamida Cell Presents New Data from Ongoing Phase 1 Study of NAM-NK and Initial Data from Phase 1/2 Study of NiCord® in Severe Aplastic Anemia at 2019 TCT Annual Meeting
2/21/2019
Data in severe aplastic anemia support potential of NiCord to treat non-malignant bone marrow failure disorders
-
DaVita Celebrates 12 Consecutive Years Among FORTUNE® Magazine's World's Most Admired Companies®
2/21/2019
Company values innovation and continuous improvement of patient care
-
Development of a Neurovascular Magnetic Particle Imaging system for non-radiative 3D perfusion angiography supported by the National Institutes of Health with a Phase II SBIR award to Magnetic Insight
2/21/2019
Magnetic Insight, Inc., leader in Magnetic Particle Imaging solutions, announced that it was awarded a Small Business Innovation Research Phase II grant from the National Institute of Drug Abuse of the National Institutes of Health under Award Number 2R44DA041814.
-
West Announces Quarterly Dividend and Share Repurchase Program payable on May 1, 2019
2/21/2019
West Pharmaceutical Services, Inc. announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share.
-
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
2/21/2019
Foresee Pharmaceuticals Co., Ltd., announced the topline results of FP-001 LMIS 25 mg phase 3 clinical trial, an open-label, single-arm study in subjects with Prostate Carcinoma.
-
ViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy System
2/21/2019
Proprietary Technology from ViewRay Enables Imaging and Treatment Enhancements
-
Crescent European Specialty Lending Announces Financing for AIO II, Holding Company of The Netherlands-Based Pharmacy Chain Medsen and Compounding Pharmacy Ceban
2/21/2019
Crescent Capital Group LP, a leading alternative credit investment firm, announced that its European Specialty Lending strategy has provided financing to support the acquisition of AIO II by funds managed by Bencis Capital Partners and management.
-
Soul Cardiovascular Sparkling Water a Good Choice During American Heart Month
2/21/2019
Infuse Your Life Health Products suggests that you try its Soul Cardiovascular Sparkling Water the next time you are thirsty instead some sugary beverage.
-
Ketologie Advocates Science Behind Keto Diet
2/21/2019
The Keto Diet, which is the most popular diet searched for on Google, is based on extensive scientific research – spanning decades - on how the human body burns fuel.
-
NPI Expands its European Portfolio in an Effort to Help Brands Penetrate the U.S. Market
2/21/2019
Nutritional Products International (NPI), already known as Europe's gateway to the U.S. market, is expanding its operations in 2019.
-
GNCC Capital, Inc. Acquires BioCann Pharma S.A.S.
2/21/2019
Company acquires Colombian Based Cannabis Pharmaceutical Grade CBD Oils Producer and Distributor
-
PureTech Health to Present at Two Upcoming Investor Conferences
2/21/2019
PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut Axis, announced two presentations at upcoming investor conferences.